GENE ONLINE|News &
Opinion
Blog

COVID-19
COVID-19 Vaccine: Russia Announces Approval of “Sputnik V” Despite Concerns Over Safety
2020-08-12
Weekly Asia Highlights- China and Japan
2020-08-06
Novavax’s COVID-19 Vaccine is Safe and Immunogenic in Early Trial
2020-08-06
Australia-Taiwan Clinical Trial and Biomedical Forum, Highlights Synergies
2020-07-30Partner
COVID-19: Immunic, Inc. Begins Phase 2 Trial of IMU-838 in fusion with Oseltamivir
2020-07-30
Top Highlights of BIO Asia-Taiwan 2020
2020-07-29Partner
Building a Biomedical Value Chain and Accelerating the Development of the Biomedical Industry
2020-07-29Partner
COVID-19 Vaccine: Moderna Begins Phase 3 COVE Study of mRNA-1273
2020-07-27
The Rise of Asia as a Destination of Biotech Investment and Opportunity
2020-07-27Partner
Innovative Diagnostics, AI, Blockchain and Telemedicine Boosts COVID-19 Fight
2020-07-26Partner
Efforts Behind the Taiwan Model of Combating COVID-19 Pandemic
2020-07-26Partner
Part I Highlights of BIO Asia-Taiwan 2020 (Day 1): The Effect of COVID-19 on Global Biotech Industry
2020-07-22Partner
COVID-19: AstraZeneca and University of Oxford’s Vaccine Candidate Shows Promise in Early Human Trials
2020-07-20
COVID-19: Medicago Begins Phase I Trials for Plant-Based VLP Vaccine
2020-07-19
Pfizer & BioNTech’s COVID-19 Vaccine Receives FDA’s Fast Track Designation
2020-07-15
1 19 20 21 22 23 27
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top